Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor

Molecular and Cellular Biology

Volumn 27, Issue 4, 2007, Pages 1334-1347

  Yang, Li V ^a   Radu, Caius G ^b   Roy, Meenakshi ^a   Lee, Sunyoung ^a   McLaughlin, Jami ^a   Teitell, Michael A ^b   Iruela Arispe, M Luisa ^a   Witte, Owen N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PH; GENE OVEREXPRESSION; GLOMERULUS; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KIDNEY BLOOD VESSEL; LUNG BLOOD VESSEL; MESANGIUM CELL; MOUSE; NONHUMAN; PERINATAL MORTALITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RESPIRATORY DISTRESS; VASCULAR DISEASE;

ANIMALS; ANIMALS, NEWBORN; AORTA; BLOOD VESSELS; CELLS, CULTURED; CROSSES, GENETIC; EMBRYO; FEMALE; GENE TARGETING; GENOTYPE; HEMORRHAGE; HUMANS; HYDROGEN-ION CONCENTRATION; LITTER SIZE; LUNG; MALE; MESANGIAL CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PENETRANCE; RECEPTORS, G-PROTEIN-COUPLED; RESPIRATORY TRACT DISEASES;

MUS;

EID: 33846912184     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01909-06     Document Type: Article

References (62)

1. An, S., C. Tsai, and E. J. Goetzl. 1995. Cloning, sequencing and tissue distribution of two related G protein-coupled receptor candidates expressed prominently in human lung tissue. FEBS Lett. 375:121-124.
2. Berger, A. C., X. Q. Wang, A. Zalatoris, J. Cenna, and J. C. Watson. 2004. A murine model of ex vivo angiogenesis using aortic disks grown in fibrin clot. Microvasc. Res. 68:179-187.
3. Betsholtz, C., P. Lindblom, M. Bjarnegard, M. Enge, H. Gerhardt, and P. Lindahl. 2004. Role of platelet-derived growth factor in mesangium development and vasculopathies: lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice. Curr. Opin. Nephrol Hypertens. 13:45-52.
4. Burbridge, M. F., D. C. West, G. Atassi, and G. C. Tucker. 1999. The effect of extracellular pH on angiogenesis in vitro. Angiogenesis 3:281-288.
5. Carey, A. V., R. M. Carey, and R. A. Gomez. 1992. Expression of alpha-smooth muscle actin in the developing kidney vasculature. Hypertension 19(2 Suppl.):II168-II175.
6. Carmeliet, P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:389-395.
7. Chang, S., B. D. Young, S. Li, X. Qi, J. A. Richardson, and E. N. Olson. 2006. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126:321-334.
8. Chung, H. A., J. Hyodo-Miura, A. Kitayama, C. Terasaka, T. Nagamune, and N. Ueno. 2004. Screening of FGF target genes in Xenopus by microarray: temporal dissection of the signalling pathway using a chemical inhibitor. Genes Cells 9:749-761.
9. Coultas, L., K. Chawengsaksophak, and J. Rossant. 2005. Endothelial cells and VEGF in vascular development. Nature 438:937-945.
10. D'Arcangelo, D., F. Facchiano, L. M. Barlucchi, G. Melillo, B. Illi, L. Testolin, C. Gaetano, and M. C. Capogrossi. 2000. Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression. Circ. Res. 86:312-318.
11. del Valle-Perez, B., O. M. Martinez-Estrada, S. Vilaro, F. Ventura, and F. Vinals. 2004. cAMP inhibits TGFbeta1-induced in vitro angiogenesis. FEBS Lett. 569:105-111.
12. Eremina, V., M. Sood, J. Haigh, A. Nagy, G. Lajoie, N. Ferrara, H. P. Gerber, Y. Kikkawa, J. H. Miner, and S. E. Quaggin. 2003. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Investig. 111:707-716.
13. Fakharzadeh, S. S., Y. Zhang, R. Sarkar, and H. H. Kazazian, Jr. 2000. Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin. Blood 95:2799-2805.
14. Fukumura, D., L. Xu, Y. Chen, T. Gohongi, B. Seed, and R. K. Jain. 2001. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res. 61:6020-6024.
15. Furumichi, T., Y. Yamada, T. Suzuki, H. Furui, K. Yamauchi, and H. Saito. 1992. Adenosine 3′:5′-cyclic monophosphate inhibits in vitro angiogenesis induced by endothelial cell growth factor. Jpn. Heart J. 33:373-382.
16. Gale, N. W., and G. D. Yancopoulos. 1999. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13:1055-1066.
17. Gatenby, R. A., and R. J. Gillies. 2004. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4:891-899.
18. Hellstrom, M., M. Kalen, P. Lindahl, A. Abramsson, and C. Betsholtz. 1999. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126:3047-3055.
19. Ishii, I., X. Ye, B. Friedman, S. Kawamura, J. J. Contos, M. A. Kingsbury, A. H. Yang, G. Zhang, J. H. Brown, and J. Chun. 2002. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. J. Biol. Chem. 277:25152-25159.
20. Ishii, S., Y. Kihara, and T. Shimizu. 2005. Identification of T cell death-associated gene 8 (TDAG8) as a novel acid sensing G-protein-coupled receptor. J. Biol. Chem. 280:9083-9087.
21. Ishizaka, H., and L. Kuo. 1996. Acidosis-induced coronary arteriolar dilation is mediated by ATP-sensitive potassium channels in vascular smooth muscle. Circ. Res. 78:50-57.
22. Kellum, J. A. 2000. Determinants of blood pH in health and disease. Crit. Care 4:6-14.
23. Kim, K. S., J. Ren, Y. Jiang, Q. Ebrahem, R. Tipps, K. Cristina, Y. J. Xiao, J. Qiao, K. L. Taylor, H. Lum, B. Anand-Apte, and Y. Xu. 2005. GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine. FASEB J. 19:819-821.
24. Kim, S., M. Bakre, H. Yin, and J. A. Varner. 2002. Inhibition of endothelial cell survival and angiogenesis by protein kinase A. J. Clin. Investig. 110:933-941.
25. Kim, S., M. Harris, and J. A. Varner. 2000. Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. J. Biol. Chem. 275:33920-33928.
26. Komatsu, M., and E. Ruoslahti. 2005. R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis. Nat. Med. 11:1346-1350.
27. Kono, M., Y. Mi, Y. Liu, T. Sasaki, M. L. Allende, Y. P. Wu, T. Yamashita, and R. L. Proia. 2004. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J. Biol. Chem. 279:29367-29373.
28. Krieger, N. S., K. K. Frick, and D. A. Bushinsky. 2004. Mechanism of acid-induced bone resorption. Curr. Opin. Nephrol. Hypertens. 13:423-436.
29. Lee, S., S. M. Jilani, G. V. Nikolova, D. Carpizo, and M. L. Iruela-Arispe. 2005. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169:681-691.
30. Lee, Y. M., C. H. Jeong, S. Y. Koo, M. J. Son, H. S. Song, S. K. Bae, J. A. Raleigh, H. Y. Chung, M. A. Yoo, and K. W. Kim. 2001. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev. Dyn. 220:175-186.
31. Lemann, J., Jr., D. A. Bushinsky, and L. L. Hamm. 2003. Bone buffering of acid and base in humans. Am. J. Physiol. Renal Physiol. 285:F811-F832.
32. Leveen, P., M. Pekny, S. Gebre-Medhin, B. Swolin, E. Larsson, and C. Betsholtz. 1994. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8:1875-1887.
33. Lindahl, P., M. Hellstrom, M. Kalen, L. Karlsson, M. Pekny, M. Pekna, P. Soriano, and C. Betsholtz. 1998. Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 125:3313-3322.
34. Ludwig, M. G., M. Vanek, D. Guerini, J. A. Gasser, C. E. Jones, U. Junker, H. Hofstetter, R. M. Wolf, and K. Seuwen. 2003. Proton-sensing G-protein-coupled receptors. Nature 425:93-98.
35. Lum, H., J. Qiao, R. J. Walter, F. Huang, P. V. Subbaiah, K. S. Kim, and O. Holian. 2003. Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 285:H1786-H1789.
36. Mahadevan, M. S., S. Baird, J. E. Bailly, G. G. Shutler, L. A. Sabourin, C. Tsilfidis, C. E. Neville, M. Narang, and R. G. Korneluk. 1995. Isolation of a novel G protein-coupled receptor (GPR4) localized to chromosome 19q13.3. Genomics 30:84-88.
37. Murakami, N., T. Yokomizo, T. Okuno, and T. Shimizu. 2004. G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine. J. Biol. Chem. 279:42484-42491.
38. Osborne, N., and D. Y. Stainier. 2003. Lipid receptors in cardiovascular development. Annu. Rev. Physiol. 65:23-43.
39. Puri, M. C., J. Rossant, K. Alitalo, A. Bernstein, and J. Partanen. 1995. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 14:5884-5891.
40. Pyne, N. J., C. Waters, N. A. Moughal, B. S. Sambi, and S. Pyne. 2003. Receptor tyrosine kinase-GPCR signal complexes. Biochem. Soc. Trans. 31:1220-1225.
41. Qiao, J., F. Huang, R. P. Naikawadi, K. S. Kim, T. Said, and H. Lum. 2006. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor, GPR4. Am. J. Physiol. Lung Cell. Mol. Physiol. 291:L91-L101.
42. Quinn, S. J., M. Bai, and E. M. Brown. 2004. pH sensing by the calcium-sensing receptor. J. Biol. Chem. 279:37241-37249.
43. Radu, C. G., D. Cheng, A. Nijagal, M. Riedinger, J. McLaughlin, L. V. Yang, J. Johnson, and O. N. Witte. 2006. Normal immune development and glucocorticoid-induced thymocyte apoptosis in mice deficient for the T-cell death-associated gene 8 receptor. Mol. Cell. Biol. 26:668-677.
44. Radu, C. G., A. Nijagal, J. McLaughlin, L. Wang, and O. N. Witte. 2005. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc. Natl. Acad. Sci. USA 102:1632-1637.
45. Shalaby, F., J. Rossant, T. P. Yamaguchi, M. Gertsenstein, X. F. Wu, M. L. Breitman, and A. C. Schuh. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
46. Shi, Q., X. Le, B. Wang, J. L. Abbruzzese, Q. Xiong, Y. He, and K. Xie. 2001. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene 20:3751-3756.
47. Soriano, P. 1994. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 8:1888-1896.
48. Sun, J., M. A. Blaskovich, R. K. Jain, F. Delarue, D. Paris, S. Brem, M. Wotoczek-Obadia, Q. Lin, D. Coppola, K. Choi, M. Mullan, A. D. Hamilton, and S. M. Sebti. 2004. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor. Cancer Res. 64:3586-3592.
49. Tao, Q., B. Lloyd, S. Lang, D. Houston, A. Zorn, and C. Wylie. 2005. A novel G protein-coupled receptor, related to GPR4, is required for assembly of the cortical actin skeleton in early Xenopus embryos. Development 132:2825-2836.
50. Taylor, P. C., and B. Sivakumar. 2005. Hypoxia and angiogenesis in rheumatoid arthritis. Curr. Opin. Rheumatol. 17:293-298.
51. Tomura, H., J. Q. Wang, M. Komachi, A. Damirin, C. Mogi, M. Tobo, J. Kon, N. Misawa, K. Sato, and F. Okajima. 2005. Prostaglandin I(2) production and cAMP accumulation in response to acidic extracellular pH through OGR1 in human aortic smooth muscle cells. J. Biol. Chem. 280:34458-34464.
52. Toyota, E., T. Matsunaga, and W. M. Chilian. 2004. Myocardial angiogenesis. Mol. Cell. Biochem. 264:35-44.
53. Tsopanoglou, N. E., G. C. Haralabopoulos, and M. E. Maragoudakis. 1994. Opposing effects on modulation of angiogenesis by protein kinase C and cAMP-mediated pathways. J. Vasc. Res. 31:195-204.
54. Van Brocklyn, J. R., B. Behbahani, and N. H. Lee. 2002. Homodimerization and heterodimerization of S1P/EDG sphingosine-1-phosphate receptors. Biochim. Biophys. Acta 1582:89-93.
55. Wahl, M. L., and D. S. Grant. 2000. Effects of microenvironmental extracellular pH and extracellular matrix proteins on angiostatin's activity and on intracellular pH. Gen. Pharmacol. 35:277-285.
56. Wang, J. Q., J. Kon, C. Mogi, M. Tobo, A. Damirin, K. Sato, M. Komachi, E. Malchinkhuu, N. Murata, T. Kimura, A. Kuwabara, K. Wakamatsu, H. Koizumi, T. Uede, G. Tsujimoto, H. Kurose, T. Sato, A. Harada, N. Misawa, H. Tomura, and F. Okajima. 2004. TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J. Biol. Chem. 279:45626-45633.
57. 2+ ions. Br. J. Pharmacol. 140:1177-1186.
58. Xu, H., J. Wu, N. Cui, L. Abdulkadir, R. Wang, J. Mao, L. R. Giwa, S. Chanchevalap, and C. Jiang. 2001. Distinct histidine residues control the acid-induced activation and inhibition of the cloned K(ATP) channel. J. Biol. Chem. 276:38690-38696.
59. Yang, A. H., I. Ishii, and J. Chun. 2002. In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. Biochim. Biophys. Acta 1582:197-203.
60. Yang, L. V., C. G. Radu, L. Wang, M. Riedinger, and O. N. Witte. 2005. Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. Blood 105:1127-1134.
61. Yun, M. R., F. Okajima, and D. S. Im. 2004. The action mode of lysophosphatidylcholine in human monocytes. J. Pharmacol. Sci. 94:45-50.
62. Zhu, K., L. M. Baudhuin, G. Hong, F. S. Williams, K. L. Cristina, J. H. Kabarowski, O. N. Witte, and Y. Xu. 2001. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J. Biol. Chem. 276:41325-41335. (Retraction, 280:43280, 2005.)